Lansoprol Capsule (Enteric Coated) EC Capsule 30 mg is a Product of the Generic Lansoprazole

What Is Lansoprol Capsule (Enteric Coated) EC Capsule 30 mg Indications and Uses?

Lansoprol is indicated for: Healing and long term management of gastroesophageal reflux disease. Healing and maintenance therapy for patients with duodenal ulcer. Relief of reflux-like symptoms (eg. Heartburn) and/or ulcer-like symptoms (eg. upper epigastric pain) associated with acid-related dyspepsia. ... Read more Lansoprol is indicated for: Healing and long term management of gastroesophageal reflux disease. Healing and maintenance therapy for patients with duodenal ulcer. Relief of reflux-like symptoms (eg. Heartburn) and/or ulcer-like symptoms (eg. upper epigastric pain) associated with acid-related dyspepsia. Healing of benign gastric ulcer. Lansoprol is also effective in patients with benign peptic lesions, including reflux oesophagitis, unresponsive to H2 receptor antagonists. Eradication of H.pylori from the upper gastro-intestinal tract in patients with duodenal ulcer or gastritis when used in combination with appropriate antibiotics.

Pharmacology (Source, Chemical and Physical Composition) Of Lansoprol Capsule (Enteric Coated) EC Capsule 30 mg

Lansoprol Capsule (Enteric Coated) EC Capsule 30 mg (Lansoprazole) is a substituted benzimidazole, and is also known as PPI due to its property to block the final step of acid secretion by inhibiting H + /K + ATPase enzyme system in gastric parietal cell. Both basal and stimulated acid are inhibited.

Dosage And Administration of Lansoprol Capsule (Enteric Coated) EC Capsule 30 mg

Benign gastric ulcer : 30 mg daily in the morning for 8 weeks. Duodenal ulcer : 30 mg daily in the morning for 4 weeks; maintenance 15 mg. NSAID-associated duodenal or gastric ulcer : 15-30 mg daily for 4 weeks, followed by a further 4 weeks if not fully healed. Zollinger-Ellison syndrome (and other hypersecretory conditions) : Initially 60 mg once daily adjusted according to response; daily doses of 120 mg or more is given in two divided doses. Gastroesophageal reflux disease : 30 mg daily in the morning for 4 weeks, followed by a further 4 weeks if not fully healed; maintenance 15-30 mg daily. Acid-related dyspepsia : 15-30 mg daily in the morning for 2-4 weeks.

Drug Interactions of Lansoprol Capsule (Enteric Coated) EC Capsule 30 mg

Caution should be exercised when oral contraceptives and preparations such as phenytion, theophylline or warfarin are taken concomitantly with the administration of Lansoprol. Antacids and sucralfate may reduce the bioavailability of Lansoprol.

Side Effects of Lansoprol Capsule (Enteric Coated) EC Capsule 30 mg

Lansoprol is well tolerated, with adverse effects generally being mild and transient. The most commonly reported adverse effects are headache, dizziness, fatigue and malaise. Gastrointestinal effects include diarrhea, constipation, abdominal pain, dyspepsia, nausea, vomiting, flatulence and dry or sore mouths. Dermatological reactions include skin rashes, urticaria and pruritus.

Precautions And Warnings for Lansoprol Capsule (Enteric Coated) EC Capsule 30 mg

Symptomatic response to therapy with Lansoprol does not preclude the presence of gastric malignancy. Lansoprol should be taken before eating.

Use During Pregnancy and Lactation

Lansoprol Capsule (Enteric Coated) EC Capsule 30 mg (Lansoprazole) has been assigned to pregnancy category B by the FDA.

Therapeutic Class

Proton Pump Inhibitor

Storage Conditions of It

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children. Thanks for using MedEx! How would you rate your experience so far?